Understanding the mechanisms controlling AQP9 expression may enable pharmacological strategies to be designed to up-regulate AQP9 in leukemia cells, hence constituting a potential method to expand the therapeutic spectrum of As2O3 in the treatment of AML. The gene discussed is AQP9; the disease is acute myeloid leukemia.